AORTIC COMPLIANCE IN YOUNG-PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引:81
|
作者
LEHMANN, ED
WATTS, GF
FATEMILANGROUDI, B
GOSLING, RG
机构
[1] UNIV LONDON,GUYS & ST THOMAS HOSP,UNITED MED & DENT SCH,DIV RADIOL SCI,LONDON,ENGLAND
[2] UNIV LONDON,GUYS & ST THOMAS HOSP,UNITED MED & DENT SCH,LONDON,ENGLAND
关键词
AORTIC COMPLIANCE; AORTIC DISTENSIBILITY; FAMILIAL HYPERCHOLESTEROLEMIA;
D O I
10.1042/cs0830717
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Aortic compliance and plasma lipid and lipoprotein levels were measured in 20 young patients with heterozygous familial hypercholesterolaemia and in 20 age- and sex-matched control subjects. 2. Patients with familial hypercholesterolaemia had significantly higher plasma cholesterol, low-density lipoprotein-cholesterol and triacylglycerol levels than control subjects (P<0.001, P<0.001 and P<0.005, respectively). The patients with familial hypercholesterolaemia also had significantly more compliant (distensible) aortas than the control subjects (P<0.001), a significant inverse correlation being observed between compliance and age (r = -0.73, P<0.001) and between compliance and mean blood pressure (r = -0.60, P<0.005). 3. When the effects of age and sex on aortic compliance were corrected for, the blood pressure effect disappeared, significant correlations being observed between normalized compliance and cholesterol (r = 0.50, P<0.03), low-density lipoprotein-cholesterol (r = 0.54, P<0.01), high-density lipoprotein-cholesterol (r = -0.44, P<0.05), low-density lipoprotein-/high-density lipoprotein-cholesterol ratio (r = 0.60, P<0.006) and duration of disease (r = 0.67, P<0.002). Multivariate regression analysis showed that the low-density lipoprotein-/high-density lipoprotein-cholesterol ratio (P<0.03) and duration of disease (P<0.04) were the best predictors of normalized compliance. 4. We suggest that the measurement of aortic compliance in young patients with familial hypercholesterolaemia may potentially be a useful, non-invasive, research tool for assessing their susceptibility to atheroma.
引用
收藏
页码:717 / 721
页数:5
相关论文
共 50 条
  • [11] Prevalence, distribution and correlates of thoracic aortic atherosclerosis in patients with heterozygous familial hypercholesterolemia
    Lambrou, SG
    Aggeli, C
    Panagiotakos, D
    Skoumas, I
    Frogoudaki, A
    Pitsavos, C
    Stefanadis, C
    Toutouzas, P
    EUROPEAN HEART JOURNAL, 2002, 23 : 55 - 55
  • [12] Heterozygous familial hypercholesterolemia
    Ozcan, Ozgr Ulas
    Gulec, Sadi
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 : 10 - 18
  • [13] Heterozygous Familial Hypercholesterolemia
    Onorato, Angela
    Sturm, Amy C.
    CIRCULATION, 2016, 133 (14) : E587 - E589
  • [14] Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
    Santos, Raul D.
    Wiegman, Albert
    Caprio, Sonia
    Cariou, Bertrand
    Averna, Maurizio
    Poulouin, Yann
    Scemama, Michel
    Manvelian, Garen
    Garon, Genevieve
    Daniels, Stephen
    JAMA PEDIATRICS, 2024, 178 (03) : 283 - 293
  • [15] Lipoprotein(a) metabolism in patients with heterozygous familial hypercholesterolemia
    Parhofer, KG
    Ritter, MM
    Geiss, C
    Schwandt, P
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 146 - 146
  • [16] Colesevelam: In pediatric patients with heterozygous familial hypercholesterolemia
    Perry C.M.
    Pediatric Drugs, 2010, 12 (2) : 133 - 140
  • [17] Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia
    Vuorio, Alpo
    Watts, Gerald F.
    Kovanen, Petri T.
    ATHEROSCLEROSIS, 2019, 281 : 25 - 30
  • [18] Valvular and supravalvular aortic stenosis in heterozygous familial hypercholesterolemia, a case report
    Ozumi, K
    Tasaki, H
    Yamashita, K
    Tanaka, S
    Sasaguri, T
    Sasaguri, Y
    Nakashima, Y
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2005, 12 (05) : 289 - 293
  • [19] When should patients with heterozygous familial hypercholesterolemia be treated?
    Rifkind, BM
    Schucker, B
    Gordon, DJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (02): : 180 - 181
  • [20] Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
    Nicholls, Stephen
    Nelson, Adam
    Ditmarsch, Marc
    Kastelein, John
    Ballantyne, Christie
    Ray, Kausik
    Navar, Ann Marie
    Nissen, Steven
    Goldberg, Anne
    Brunham, Liam
    Wuerdeman, Erin
    Neild, Annie
    Kling, Douglas
    Hsieh, Andrew
    Ference, Brian
    Laufs, Ulrich
    Banach, Maciej
    Mehran, Roxana
    Catapano, Alberico
    Davidson, Michael
    CIRCULATION, 2024, 150 (25) : E729 - E730